The DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
Factors affecting the development of adverse drug reactions (Review article)
Open accessAbstract
OBJECTIVES: To discuss the effect of certain factors on the occurrence of Adverse Drug Reactions (ADRs). DATA SOURCES: A systematic review of the literature in the period between 1991 and 2012 was made based on PubMed, the Cochrane database of systematic reviews, EMBASE and IDIS. Key words used were: medication error, adverse drug reaction, iatrogenic disease factors, ambulatory care, primary health care, side effects and treatment hazards. SUMMARY: Many factors play a crucial role in the occurrence of ADRs, some of these are patient related, drug related or socially related factors. Age for instance has a very critical impact on the occurrence of ADRs, both very young and very old patients are more vulnerable to these reactions than other age groups. Alcohol intake also has a crucial impact on ADRs. Other factors are gender, race, pregnancy, breast feeding, kidney problems, liver function, drug dose and frequency and many other factors. The effect of these factors on ADRs is well documented in the medical literature. Taking these factors into consideration during medical evaluation enables medical practitioners to choose the best drug regimen. CONCLUSION: Many factors affect the occurrence of ADRs. Some of these factors can be changed like smoking or alcohol intake others cannot be changed like age, presence of other diseases or genetic factors. Understanding the different effects of these factors on ADRs enables healthcare professionals to choose the most appropriate medication for that particular patient. It also helps the healthcare professionals to give the best advice to patients. Pharmacogenomics is the most recent science which emphasizes the genetic predisposition of ADRs. This innovative science provides a new perspective in dealing with the decision making process of drug selection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Incidence of Adverse Drug Reactions in Hospitalized Patients: A Meta-analysis of Prospective Studies
Lazarou, J., Pomeranz, B. H., & Corey, P. N. (1998) · JAMA · doi:10.1001/jama.279.15.1200 · Cited by 4,807
Leape, L. L., Brennan, T. A., Laird, N., Lawthers, A. G., Localio, A. R., Barnes, B. A., Hebert, L., Newhouse, J. P., Weiler, P. C., & Hiatt, H. (1991) · New England Journal of Medicine · doi:10.1056/nejm199102073240605 · Cited by 3,711
Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients
Pirmohamed, M., James, S., Meakin, S., Green, C., Scott, A. K., Walley, T. J., Farrar, K., Park, B. K., & Breckenridge, A. M. (2004) · BMJ · doi:10.1136/bmj.329.7456.15 · Cited by 3,230
Adverse drug reactions: definitions, diagnosis, and management
Edwards, I. R., & Aronson, J. K. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02799-9 · Cited by 2,979
Medication Errors and Adverse Drug Events in Pediatric Inpatients
Kaushal, R. (2001) · JAMA · doi:10.1001/jama.285.16.2114 · Cited by 1,917
The pharmacological basis of therapeutics
Starr, I. (1941) · American Heart Journal · doi:10.1016/s0002-8703(41)90958-4 · Cited by 1,902
The Incidence and Severity of Adverse Events Affecting Patients after Discharge from the Hospital
Forster, A. J., Murff, H. J., Peterson, J. F., Gandhi, T. K., & Bates, D. W. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-3-200302040-00007 · Cited by 1,886
Kaufman, D. W., Kelly, J. P., Rosenberg, L., Anderson, T. E., & Mitchell, A. A. (2002) · JAMA · doi:10.1001/jama.287.3.337 · Cited by 1,845
Incidence and Preventability of Adverse Drug Events Among Older Persons in the Ambulatory Setting
Gurwitz, J. H., Field, T. S., Harrold, L. R., Rothschild, J., Debellis, K., Seger, A. C., Cadoret, C., Fish, L. S., Garber, L., Kelleher, M., et al. (2003) · JAMA · doi:10.1001/jama.289.9.1107 · Cited by 1,676
Error, stress, and teamwork in medicine and aviation: cross sectional surveys
Sexton, J. B. (2000) · BMJ · doi:10.1136/bmj.320.7237.745 · Cited by 1,611
Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose
Chung, C. H., Mirakhur, B., Chan, E., Le, Q.-T., Berlin, J., Morse, M., Murphy, B. A., Satinover, S. M., Hosen, J., Mauro, D., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa074943 · Cited by 1,521
Metabolism and Disposition Kinetics of Nicotine
Hukkanen, J., Jacob, P., & Benowitz, N. L. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.1.3 · Cited by 1,321
Gender and Health: An Update on Hypotheses and Evidence
Verbrugge, L. M. (1985) · Journal of Health and Social Behavior · doi:10.2307/2136750 · Cited by 1,245
Mechanism-Based Concepts of Size and Maturity in Pharmacokinetics
Anderson, B. J., & Holford, N. H. G. (2008) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.48.113006.094708 · Cited by 1,125
THE PHARMACOLOGICAL BASIS OF THERAPEUTICS
GOODMAN, L. S., GILMAN, A., & Lasdon, W. S. (1967) · The American Journal of the Medical Sciences · doi:10.1097/00000441-196701000-00028 · Cited by 1,018
Trends in the Leading Causes of Death in the United States, 1970-2002
Jemal, A. (2005) · JAMA · doi:10.1001/jama.294.10.1255 · Cited by 987
Clinical risk factors, DNA variants, and the development of type 2 diabetes
Lyssenko, V., Jonsson, A., Almgren, P., Pulizzi, N., Isomaa, B., Tuomi, T., Berglund, G., Altshuler, D., Nilsson, P., & Groop, L. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801869 · Cited by 938
Pharmacokinetics and drug metabolism in the elderly
Klotz, U. (2009) · Drug Metabolism Reviews · doi:10.1080/03602530902722679 · Cited by 826
Sex Differences in the Expression of Hepatic Drug Metabolizing Enzymes
Waxman, D. J., & Holloway, M. G. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.056705 · Cited by 815
Genotype score in addition to common risk factors for prediction of type 2 diabetes
Meigs, J. B., Shrader, P., Sullivan, L. M., McAteer, J. B., Fox, C. S., Dupuis, J., Manning, A. K., Florez, J. C., Wilson, P. W. F., D'Agostino, R. B., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0804742 · Cited by 759 · cited 1×
“Recent development suggests that ADRs may be avoided by individualizing the therapeutic plan according to genetics (Meigs et al., 2008).”
Potential Role of Pharmacogenomics in Reducing Adverse Drug Reactions: A Systematic Review
Phillips, K. A., Veenstra, D. L., Oren, E., Lee, J. K., & Sadee, W. (2001) · JAMA · doi:10.1001/jama.286.18.2270 · Cited by 705
Drug Interactions with Tobacco Smoking: An Update
Zevin, S., & Benowitz, N. L. (1999) · Clinical Pharmacokinetics · doi:10.2165/00003088-199936060-00004 · Cited by 692
The Teratogenicity of Anticonvulsant Drugs
Holmes, L. B., Harvey, E. A., Coull, B. A., Huntington, K. B., Khoshbin, S., Hayes, A. M., & Ryan, L. M. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104123441504 · Cited by 655
Optimising drug treatment for elderly people: the prescribing cascade
Rochon, P. A., & Gurwitz, J. H. (1997) · BMJ · doi:10.1136/bmj.315.7115.1096 · Cited by 609
Medication Use Leading to Emergency Department Visits for Adverse Drug Events in Older Adults
Budnitz, D. S., Shehab, N., Kegler, S. R., & Richards, C. L. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-11-200712040-00006 · Cited by 607
Depressive Symptoms and Risks of Coronary Heart Disease and Mortality in Elderly Americans
Ariyo, A. A., Haan, M., Tangen, C. M., Rutledge, J. C., Cushman, M., Dobs, A., & Furberg, C. D. (2000) · Circulation · doi:10.1161/01.cir.102.15.1773 · Cited by 556
Polypharmacy and Prescribing Quality in Older People
Steinman, M. A., Seth Landefeld, C., Rosenthal, G. E., Berthenthal, D., Sen, S., & Kaboli, P. J. (2006) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2006.00889.x · Cited by 537
Human renal function maturation: a quantitative description using weight and postmenstrual age
Rhodin, M. M., Anderson, B. J., Peters, A. M., Coulthard, M. G., Wilkins, B., Cole, M., Chatelut, E., Grubb, A., Veal, G. J., Keir, M. J., et al. (2009) · Pediatric Nephrology · doi:10.1007/s00467-008-0997-5 · Cited by 497
Polypharmacy: Misleading, but manageable
Bushardt, R. (2008) · Clinical Interventions in Aging · doi:10.2147/cia.s2468 · Cited by 489
(1977) · PubMed · Cited by 488
Adverse drug reactions in elderly patients
Routledge, P. A., O'Mahony, M. S., & Woodhouse, K. W. (2004) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2003.01875.x · Cited by 476
Drug interactions with smoking
Kroon, L. A. (2007) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp060414 · Cited by 345
Genetic susceptibility to adverse drug reactions
Pirmohamed, M., & Park, B. K. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01717-x · Cited by 328
Valvular Heart Disease: Aortic Regurgitation
Bekeredjian, R., & Grayburn, P. A. (2005) · Circulation · doi:10.1161/circulationaha.104.488825 · Cited by 302
Chemokine-mediated control of T cell traffic in lymphoid and peripheral tissues
Ebert, L. M., Schaerli, P., & Moser, B. (2005) · Molecular Immunology · doi:10.1016/j.molimm.2004.06.040 · Cited by 294
Effects of renal failure on drug transport and metabolism
Sun, H., Frassetto, L., & Benet, L. Z. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.05.010 · Cited by 290
Therapeutic implications of the gender-specific aspects of cardiovascular disease
Regitz-Zagrosek, V. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2032 · Cited by 284
Efficacy of low and high dose inhaled corticosteroid in smokers versus non-smokers with mild asthma
Tomlinson, J. E. M. (2005) · Thorax · doi:10.1136/thx.2004.033688 · Cited by 277
Role of Drug Disposition in Drug Hypersensitivity: A Chemical, Molecular, and Clinical Perspective
Park, B. K., Pirmohamed, M., & Kitteringham, N. R. (1998) · Chemical Research in Toxicology · doi:10.1021/tx980058f · Cited by 267
Outpatient prescribing errors and the impact of computerized prescribing
Gandhi, T. K., Weingart, S. N., Seger, A. C., Borus, J., Burdick, E., Poon, E. G., Leape, L. L., & Bates, D. W. (2005) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2005.0194.x · Cited by 255
Time response of cytochrome P450 1A2 activity on cessation of heavy smoking*1
FABER, M. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2004.04.003 · Cited by 250
McDowell, S. E., Coleman, J. J., & Ferner, R. E. (2006) · BMJ · doi:10.1136/bmj.38803.528113.55 · Cited by 248
Drug-Drug Interactions Associated with Length of Stay and Cost of Hospitalization
Moura, C. S., Acurcio, F. A., & Belo, N. O. (2009) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j35c7z · Cited by 247
Evaluating men's involvement as a strategy in sexual and reproductive health promotion
Sternberg, P. (2004) · Health Promotion International · doi:10.1093/heapro/dah312 · Cited by 241
Applying Mechanisms of Chemical Toxicity to Predict Drug Safety
Guengerich, F. P., & MacDonald, J. S. (2007) · Chemical Research in Toxicology · doi:10.1021/tx600260a · Cited by 231
Cornelis, M. C., Qi, L., Zhang, C., Kraft, P., Manson, J., Cai, T., Hunter, D. J., & Hu, F. B. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-8-200904210-00008 · Cited by 230
JOSE, J., & RAO, P. (2006) · Pharmacological Research · doi:10.1016/j.phrs.2006.05.003 · Cited by 195
Risk Factors for Adverse Drug Events: A 10-Year Analysis
Evans, R. S., Lloyd, J. F., Stoddard, G. J., Nebeker, J. R., & Samore, M. H. (2005) · Annals of Pharmacotherapy · doi:10.1345/aph.1e642 · Cited by 193
Assessment of drug-induced hepatotoxicity in clinical practice: A challenge for gastroenterologists
Andrade, R. J., Robles, M., Fernández-Castañer, A., López-Ortega, S., López-Vega, M.-C., & Lucena, M.-I. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i3.329 · Cited by 188
Medication Errors and Adverse Drug Events in Pediatric Inpatients
Bailey, C. R. (2002) · Survey of Anesthesiology · doi:10.1097/00132586-200206000-00041 · Cited by 186
Adverse drug reaction risk factors in older outpatients
Hajjar, E. R., Hanlon, J. T., Artz, M. B., Lindblad, C. I., Pieper, C. F., Sloane, R. J., Ruby, C. M., & Schmader, K. E. (2003) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/s1543-5946(03)90004-3 · Cited by 182
Huang, S.-M. (2004) · Applications of Pharmacokinetic Principles in Drug Development · doi:10.1007/978-1-4419-9216-1_10 · Cited by 181
Adverse drug reactions in childhood: a review of prospective studies and safety alerts
Clavenna, A., & Bonati, M. (2009) · Archives of Disease in Childhood · doi:10.1136/adc.2008.154377 · Cited by 179
A survey on polypharmacy and use of inappropriate medications
Rambhade, S., Shrivastava, A., Rambhade, A., Chakarborty, A., & Patil, U. (2012) · Toxicology International · doi:10.4103/0971-6580.94506 · Cited by 170
How Well Do Women Adapt to Changes in Their Body Size and Shape across the Course of Pregnancy?
Duncombe, D., Wertheim, E. H., Skouteris, H., Paxton, S. J., & Kelly, L. (2008) · Journal of Health Psychology · doi:10.1177/1359105308088521 · Cited by 164
Changes in Antidepressant Metabolism and Dosing Across Pregnancy and Early Postpartum
Sit, D. K. Y., Perel, J. M., Helsel, J. C., & Wisner, K. L. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0419 · Cited by 161
Zhao, W., Elie, V, Roussey, G., Brochard, K., Niaudet, P., Leroy, V, Loirat, C., Cochat, P., Cloarec, S., André, J. L., et al. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.210 · Cited by 158
HLA Genotype and Carbamazepine-Induced Cutaneous Adverse Drug Reactions: A Systematic Review
Yip, V. L. M., Marson, A. G., Jorgensen, A., Pirmohamed, M., & Alfirevic, A. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.189 · Cited by 154
Peng, J., Gurantz, D., Tran, V., Cowling, R. T., & Greenberg, B. (2002) · Circulation Research · doi:10.1161/01.res.0000047090.08299.d5 · Cited by 154
Optimizing Pediatric Dosing: A Developmental Pharmacologic Approach
Anderson, G. D., & Lynn, A. M. (2009) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.29.6.680 · Cited by 146
The Liver: A Special Case in Transplantation Tolerance
Benseler, V., McCaughan, G. W., Schlitt, H. J., Bishop, G. A., Bowen, D. G., & Bertolino, P. (2007) · Seminars in Liver Disease · doi:10.1055/s-2007-979471 · Cited by 146
Adverse events with use of antiepileptic drugs: a prescription and event symmetry analysis
Tsiropoulos, I., Andersen, M. T., & Hallas, J. (2009) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1736 · Cited by 138
The Impact of Smoking on Inhaled Insulin
Himmelmänn, A., JENDLE, J. H., Mellén, A., Petersen, A. H., Dahl, U., & Wollmer, P. (2003) · Diabetes Care · doi:10.2337/diacare.26.3.677 · Cited by 128
Masubuchi, N., Makino, C., & Murayama, N. (2007) · Chemical Research in Toxicology · doi:10.1021/tx060234h · Cited by 123
Incidence of Hepatotoxicity Due to Antitubercular Medicines and Assessment of Risk Factors
Shakya, R., Rao, B. S., & Shrestha, B. (2004) · Annals of Pharmacotherapy · doi:10.1345/aph.1d525 · Cited by 123
Kalisch, L. M., Caughey, G. E., Roughead, E. E., & Gilbert, A. L. (2011) · Australian Prescriber · doi:10.18773/austprescr.2011.084 · Cited by 123
Potential for Alcohol and Prescription Drug Interactions in Older People
Pringle, K. E., Ahern, F. M., Heller, D. A., Gold, C. H., & Brown, T. V. (2005) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2005.00474.x · Cited by 120
Labbé, L., Sirois, C., Pilote, S., Arseneault, M., Robitaille, N., Turgeon, J., & Hamelin, B. A. (2000) · Pharmacogenetics · doi:10.1097/00008571-200007000-00006 · Cited by 112
Hermida, R. C., Ayala, D. E., Calvo, C., & López, J. E. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.08.071 · Cited by 111 · cited 1×
“Taking Bisphosphonates at bed time may lead to esophagitis, the antiplatelet effect of aspirin when taking in the evening is more potent that in the morning (Hermida et al., 2005).”
Obreli-Neto, P. R., Nobili, A., Baldoni, A. O., Guidoni, C. M., de Lyra, D. P., Pilger, D. A., Duzanski, J., Tettamanti, M., Cruciol-Souza, J. M., Gaeti, W. P., et al. (2012) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-012-1309-3 · Cited by 110
Using Genome-Wide Association Studies to Identify Genes Important in Serious Adverse Drug Reactions
Daly, A. K. (2011) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134743 · Cited by 105
Pellicer, A., Bravo, M. C., Madero, R., Salas, S., Quero, J., & Cabañas, F. (2009) · PEDIATRICS · doi:10.1542/peds.2008-0673 · Cited by 103
Reuben, A. (2007) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e3280f27582 · Cited by 100
Smoking and family history and risk of aneurysmal subarachnoid hemorrhage
Woo, D., Khoury, J. C., Haverbusch, M. A., Sekar, P., Flaherty, M. L., Kleindorfer, D., D, B. M. K. M., Moomaw, C. J., Deka, R., & Broderick, J. P. (2009) · Neurology · doi:10.1212/01.wnl.0000338567.90260.46 · Cited by 98
Risk Factors Associated with Adverse Drug Reactions Following Hospital Admission
Zopf, Y., Rabe, C., Neubert, A. C., et al. (2008) · Drug Safety · doi:10.2165/00002018-200831090-00007 · Cited by 97
Lai, S., Lin, C., Liao, K., Su, L., Sung, F., & Lin, C. (2012) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/j.1447-0594.2011.00800.x · Cited by 97
Sex differences in adverse reactions to antiretroviral drugs.
Ofotokun, I., & Pomeroy, C. (2003) · PubMed · Cited by 94
The Role of Active Metabolites in Drug Toxicity
Pirmohamed, M., Kitteringham, N. R., & Park, B. K. (1994) · Drug Safety · doi:10.2165/00002018-199411020-00006 · Cited by 86
Harboe, T., Johansson, S. G. O., Florvaag, E., et al. (2007) · Allergy · doi:10.1111/j.1398-9995.2007.01554.x · Cited by 86
Complex Drug-Drug-Disease Interactions Between Amiodarone, Warfarin, and the Thyroid Gland
Kurnik, D., Loebstein, R., Farfel, Z., Ezra, ., Halkin, H., & Olchovsky, D. (2004) · Medicine · doi:10.1097/01.md.0000123095.65294.34 · Cited by 83
Meyer, R., Laz, E. V., Su, T., & Waxman, D. J. (2009) · Molecular Endocrinology · doi:10.1210/me.2009-0242 · Cited by 82
The distribution and gender difference of CYP3A activity in Chinese subjects
Zhu, B. Y., Liu, Z., Chen, G., et al. (2003) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2003.01728.x · Cited by 78
Polypharmacy and Food–Drug Interactions Among Older Persons: A Review
Heuberger, R. (2012) · Journal of Nutrition in Gerontology and Geriatrics · doi:10.1080/21551197.2012.729902 · Cited by 74
Brundage, S. C. (2002) · PubMed · Cited by 72
Zadák, Z., Hyšpler, R., Tichá, A., & Vlček, J. (2012) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e32835b612e · Cited by 72
Caughey, G., Roughead, E., Pratt, N., Shakib, S., Vitry, A., & Gilbert, A. (2010) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2009 · Cited by 68
Consensus List of Signals to Detect Potential Adverse Drug Reactions in Nursing Homes
Handler, S. M., Hanlon, J. T., Perera, S., Roumani, Y. F., Nace, D. A., Fridsma, D. B., Saul, M. I., Castle, N. G., & Studenski, S. A. (2008) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2008.01665.x · Cited by 67
Pack, A. M., Davis, A. R., Kritzer, J., Yoon, A., & Camus, A. (2009) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2009.01.024 · Cited by 67
ACE Inhibitor–Induced Angioedema
Baram, M., Kommuri, A., Sellers, S. A., & Cohn, J. R. (2013) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2013.07.005 · Cited by 63
Schwingl, P. J., Ory, H. W., & Visness, C. M. (1999) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(99)70182-1 · Cited by 62
Effect of chronic renal failure on the disposition of highly hepatically metabolized drugs
Yuan, R., & Venitz, J. (2000) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp38245 · Cited by 59
Harugeri, A., Parthasarathi, G., Ramesh, M., Guido, S., & Basavanagowdappa, H. (2011) · Journal of Postgraduate Medicine · doi:10.4103/0022-3859.85201 · Cited by 58
O ral A dverse D rug R eactions to C ardiovascular D rugs
Torpet, L. A., Kragelund, C., Reibel, J., & Nauntofte, B. (2004) · Critical Reviews in Oral Biology & Medicine · doi:10.1177/154411130401500104 · Cited by 58
Sex differences in cardiovascular drug‐induced adverse reactions causing hospital admissions
Rodenburg, E. M., Stricker, B. H. C., & Visser, L. E. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04310.x · Cited by 53
Ibáñez, L., López‐Bermejo, A., Díaz, M., Marcos, M. V., Casano, P., & de Zegher, F. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2176 · Cited by 53
Morimoto, T., Gandhi, T. K., Fiskio, J. M., Seger, A. C., So, J. W., Cook, E. F., Fukui, T., & Bates, D. W. (2004) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2004.30016.x · Cited by 51
Ensom, M. H. H. (2000) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.20.6.523.35161 · Cited by 50
Effects of sex on the pharmacokinetic and pharmacodynamic properties of quinidine
El‐Eraky, H., & Thomas, S. H. L. (2003) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2003.01865.x · Cited by 48
Schmid, D. A., Depta, J. P. H., Lüthi, M., & Pichler, W. J. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.021576 · Cited by 44
Chang, Y., Huang, S., Tao, P., & Chien, C. (2012) · BMC Nephrology · doi:10.1186/1471-2369-13-96 · Cited by 42
Corrao, G., Botteri, E., Bagnardi, V., Zambon, A., Carobbio, A., Falcone, C., & Leoni, O. (2004) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1019 · Cited by 40
Angioedema and angiotensin‐converting enzyme inhibitors: Are demographics a risk?
Davis, E. M., & Devaiah, A. K. (2008) · Otolaryngology · doi:10.1016/j.otohns.2008.03.029 · Cited by 38
Risk Factors for Self-Reported Adverse Drug Events Among Medicare Enrollees
Oladimeji, O., Farris, K. B., Urmie, J. M., & Doucette, W. R. (2007) · Annals of Pharmacotherapy · doi:10.1345/aph.1k073 · Cited by 38
The Menstrual Cycle and Drug Metabolism
Mitchell, S., Smith, R. L., & Waring, R. H. (2009) · Current Drug Metabolism · doi:10.2174/138920009788897966 · Cited by 28
Polypharmacy or medication washout: an old tool revisited
Hoffman, D. A., Schiller, Greenblatt, J., & Iosifescu, D. V. (2011) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s24375 · Cited by 25
Angiotensin-Converting Enzyme and Dipeptidyl Peptidase IV Inhibitors
Grouzmann, E., Livio, F., & Buclin, T. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.135244 · Cited by 25
Impact of Access to Recovery services on alcohol/drug treatment outcomes
Krupski, A., Campbell, K. M., Joesch, J. M., Lucenko, B. A., & Roy‐Byrne, P. (2009) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2009.05.007 · Cited by 23
Are Women With Functional Limitations at High Risk of Underutilization of Mammography Screening?
Ahmed, N. U., Smith, G. L., Haber, G., & Belcon, M. C. (2008) · Women s Health Issues · doi:10.1016/j.whi.2008.09.001 · Cited by 22
Bruce, R. D., Altice, F. L., & FRIEDLAND, G. H. (2008) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.1.1.115 · Cited by 22
Schoderboeck, L., Adzemovic, M. Z., Nicolussi, E.-M., Crupinschi, C., Hochmeister, S., Fischer, M.-T., Lassmann, H., & Bradl, M. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.05.026 · Cited by 21
Brown, R. L., Dimond, A. R., Hulisz, D. T., Saunders, L. A., & Bobula, J. A. (2007) · Journal of the American Pharmacists Association · doi:10.1331/xwh7-r0x8-1817-8n2l · Cited by 20
Drug transporters and renal drug disposition in the newborn
Gregori, S. D., Gregori, M. D., Ranzani, G. N., Borghesi, A., Regazzi, M. B., & Stronati, M. (2009) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767050903184470 · Cited by 16
First Trimester PAPP-A Levels Associated with Early Prediction of Pregnancy Induced Hypertension
Meloni, P., D’Angeli, I., Piazze, J., Cerekja, A., Simari, T., Pala, A., Anceschi, M. M., Guglietta, M., Izzo, P., & Izzo, L. (2009) · Hypertension in Pregnancy · doi:10.3109/10641950802601211 · Cited by 16
Alomar, M. J., & Strauch, C. C. (2010) · American Journal of Pharmacology and Toxicology · doi:10.3844/ajptsp.2010.89.94 · Cited by 9
Self-citationDas ACE-Hemmer-induzierte Angioödem
Baş, M., Hoffmann, T. K., Kojda, G., & Bier, H. (2007) · Laryngo-Rhino-Otologie · doi:10.1055/s-2007-966932 · Cited by 8
Cited by
Al-Worafi, Y. M. (2020) · Drug Safety in Developing Countries · doi:10.1016/b978-0-12-819837-7.00005-4 · Cited by 390
Lorenzo-Almorós, A., Hang, T., Peiró, C., Soriano-Guillén, L., Egido, J., Tuñón, J., & Lorenzo, Ó. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0935-9 · Cited by 202
Shukla, A. K., Jhaj, R., Misra, S., Ahmed, S. N., Nanda, M., & Chaudhary, D. (2021) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_831_21 · Cited by 93
Cho, B., Roh, J.-W., Park, J., Jeong, K., Kim, T.-H., Kim, Y. S., Kwon, Y.-S., Cho, C.-H., Park, S. H., & Kim, S. H. (2020) · Reproductive Sciences · doi:10.1007/s43032-019-00094-5 · Cited by 44
Xu, Y., Patel, D. N., Ng, S.-L. P., Tan, S.-H., Toh, D., Poh, J., Lim, A. T., Chan, C.-L., Low, M.-Y., & Koh, H.-L. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00167 · Cited by 22
Metadata
- Authors
- Alomar, M. J.
- Venue
- Saudi Pharmaceutical Journal
- Published
- 2014-04
- Volume
- 22
- Issue
- 2
- Pages
- 83-94
- ISSN
- 1319-0164 (ISSN-L)
- OpenAlex
- W1991864978
- Cited by
- 484
- References
- 115
- FWCI
- 22.43
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.